Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Evaluation of Sunscreens Under Actual Use Conditions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02952235
Recruitment Status : Completed
First Posted : November 2, 2016
Last Update Posted : June 8, 2017
Sponsor:
Information provided by (Responsible Party):
Johnson & Johnson Consumer and Personal Products Worldwide

Brief Summary:
Use of two high SPF sunscreens under actual use conditions.

Condition or disease Intervention/treatment Phase
Sun Protection Other: SPF50+ Other: SPF100+ Not Applicable

Detailed Description:
To evaluate the difference in the level of sunburn (erythema) protection following a single period of natural sunlight exposure afforded by application of SPF 50+ and SPF 100+ sunscreens.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 199 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Other
Official Title: A Single Center, Randomized, Split-Face, Double-Blinded, Single Sun Exposure Evaluation of Sunscreens of SPF 50+ and Above Under Actual Use Conditions
Actual Study Start Date : March 31, 2016
Actual Primary Completion Date : March 31, 2016
Actual Study Completion Date : March 31, 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sun Exposure

Arm Intervention/treatment
SPF50+
SPF 50+ assigned to Left side of face SPF 100+ assigned to Right side of face
Other: SPF50+
Sun protection
Other Name: Sunscreens

SPF100+
SPF 100+ assigned to Left side of face SPF 50+ assigned to Right side of face
Other: SPF100+
Sun protection
Other Name: Sunscreens




Primary Outcome Measures :
  1. Side-by-side Comparison (overall difference) of Sunburn. [ Time Frame: Day 2 ]
    The side-by-side comparison utilized the following condensed two side overall difference scale: L1 = subject's left side noticeably more sunburned than right side, 0= no difference in sunburn, R1= subject's right side noticeably more sunburned than left side. The 0 outcomes were excluded from the analysis.


Secondary Outcome Measures :
  1. Difference in Erythema Score Between Left and Right Sides at Day 2 [ Time Frame: Day 2 ]
    Erythema was assessed using a scale of 0 = no burn, 1 = possible burn, not clearly defined; 2 = defined redness clearly caused by UV; 3 = severe sunburn with pronounced redness; and 4 = edema and blisters



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Males and Females with Fitzpatrick Skin Types I-III
  2. At least 18 years old
  3. Able to read, write, speak and understand the English language.
  4. Has personally read, signed, and dated the Informed Consent Form (including HIPAA disclosure) and Photograph Release
  5. Generally in good health based on medical history reported by the subject
  6. Healthy male or female subjects with no history or evidence of clinically relevant medical disorder, as determined from a brief medical history interview.
  7. Willing and able to follow the study instructions, including:

Remain outdoors for at least 5 hours on Day 1 during the study with face and neck uncovered (as much as possible)

  • Apply the test products (sunscreen) to designated sides of the face and neck
  • Remove any make-up, sunscreen, or other facial products at baseline prior to applying test product. Use test product in place of current sun protection topical skincare products (this includes make-up)
  • Attend scheduled visits and intend to successfully complete the study
  • Return ALL study products at Day 2 exit visit
  • Refrain from using other sunscreen products or tanning bed use during the duration of the study.

Exclusion Criteria:

  1. Individuals with known allergies or sensitivities to sunscreens or any ingredient contained in the test products or common topical skincare products, including adhesives.
  2. Observable Sunburn (erythema score above 0.5) on the face and neck as determined by the PI or designee.
  3. Women known to be pregnant or nursing.
  4. Individuals with any disease or condition of the skin (e.g., active [i.e. flaring] eczema or psoriasis, skin cancer, polymorphic light eruption (PMLE), systemic lupus erythematous (SLE), xerodermapigmentosa) that could interfere with the study or increase risk to the subject.
  5. Individuals with self-reported UNCONTROLLED metabolic conditions, such as diabetes, hypertension, hyper/hypothyroidism, hypercholesterolemia
  6. Subjects who are taking medication for chronic conditions that may make a subject more sun sensitive (e.g., Tetracyclines, antifungals, certain diuretics, etc.)
  7. Skin diseases on tested sites (e.g., photosensitivity disorders, etc.), which may influence the outcome of the study
  8. Wearing of a full head covered ski mask.
  9. An individual who has any condition which in the PI's judgment makes the candidate an inappropriate subject for study participation
  10. Subjects who are related to those persons involved directly or indirectly with the conduct of this study (i.e., PI, sub-investigators, study coordinators, other site personnel, employees of Johnson & Johnson subsidiaries, contractors of Johnson & Johnson, and the families of each)
  11. Individuals with a condition or situation which, in the PI's opinion, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study
  12. Individual viewed by the PI as not being able to complete the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02952235


Sponsors and Collaborators
Johnson & Johnson Consumer and Personal Products Worldwide
Investigators
Layout table for investigator information
Study Director: Joshua Williams, PhD Sponsor GmbH

Layout table for additonal information
Responsible Party: Johnson & Johnson Consumer and Personal Products Worldwide
ClinicalTrials.gov Identifier: NCT02952235    
Other Study ID Numbers: CO-151112132858-SACT
First Posted: November 2, 2016    Key Record Dates
Last Update Posted: June 8, 2017
Last Verified: June 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Sunscreening Agents
Radiation-Protective Agents
Protective Agents
Physiological Effects of Drugs
Dermatologic Agents